✅ NHS-sourced information. General health information only — not personal medical advice. Always consult your GP or specialist.

NICE 09 September 2026

Nemolizumab for treating moderate to severe prurigo nodularis

TA1191

New Guidance: NICE
View official guidance ↗

TA1191

📋 What this means for you: Speak to your GP or specialist to understand how this guidance affects your care.

This article summarises content originally published by NICE. PatientIQ provides independent plain English summaries.

Free health updates

Stay one step ahead
of your condition.

New trial alerts, treatment news, and plain-English updates — matched to your condition. Free forever.

No spam. Unsubscribe anytime. Your data is private.